Application Nr Approved Date Route Status External Links
ANDA207518 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Azacitidine For Injection Is A Nucleoside Metabolic Inhibitor Indicated For The Treatment Of Patients With The Following Fab Myelodysplastic Syndrome (Mds) Subtypes: Refractory Anemia (Ra) Or Refractory Anemia With Ringed Sideroblasts (Rars) (If Accompanied By Neutropenia Or Thrombocytopenia Or Requiring Transfusions), Refractory Anemia With Excess Blasts (Raeb), Refractory Anemia With Excess Blasts In Transformation (Raeb-T), And Chronic Myelomonocytic Leukemia (Cmmol). ( 1 ) 1.1 Myelodysplastic Syndromes (Mds) Azacitidine For Injection Is Indicated For Treatment Of Patients With The Following French-American-British (Fab) Myelodysplastic Syndrome Subtypes: Refractory Anemia (Ra) Or Refractory Anemia With Ringed Sideroblasts (If Accompanied By Neutropenia Or Thrombocytopenia Or Requiring Transfusions), Refractory Anemia With Excess Blasts (Raeb), Refractory Anemia With Excess Blasts In Transformation (Raeb-T), And Chronic Myelomonocytic Leukemia (Cmmol).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Azacitidine AZACITIDINE ZINC3861768

Comments